25 LLC’s Organon & Co OGN Stock Holding History

25 LLC’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-26	Closed	-$539	–	386
2023 Q2	$539	Buy	26 +4	+18%	+$87	﹤0.01%	474
2023 Q1	$481	Buy	+22	New	+$591	﹤0.01%	420

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

25 LLC's OGN Position: Q3 2023 in Review

25 LLC sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 26 shares — an estimated $539 sold.

25 LLC first reported a position in OGN in Q1 2023 and held it in 2 quarters. The position peaked at $539 in Q2 2023. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

25 LLC reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
25 LLC sold 26 Organon & Co shares in Q3 2023, an estimated $539.
25 LLC first reported a position in Organon & Co in Q1 2023 and held it in 2 quarters.
25 LLC's Organon & Co position peaked at $539 in Q2 2023.
730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.